![Merdad Parsey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Merdad Parsey
Direktor/Vorstandsmitglied bei
ARRIVENT BIOPHARMA, INC.
Vermögen: 216 560 $ am 31.08.2026
Profil
Dr. Merdad V. Parsey ist ein unabhängiger Direktor bei Arcus Biosciences, Inc. und ein Chief Medical Officer bei Gilead Sciences, Inc. Er ist Mitglied des Board of Directors bei Arcus Biosciences, Inc. und Sagimet Biosciences, Inc. Dr. Parsey war zuvor als Senior Medical Director bei Regeneron Pharmaceuticals, Inc. angestellt, als Senior Director-Medical Group bei Genentech, Inc. als Associate Medical Director bei Merck & Co, Inc. als Director-Critical Care Medicine bei der New York University School of Medicine, als Mitglied bei der Roche Group und als Senior Medical Director bei Sunovion Pharmaceuticals, Inc. Er erhielt seinen Doktortitel von der University of Maryland.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARDELYX, INC. 0.02% | 16.06.2026 | 57’291 ( 0.02% ) | 216 560 $ | 31.08.2026 |
| 18.06.2026 | 0 ( -.--% ) | - $ | 31.08.2026 |
Aktuelle Nachrichten zu Merdad Parsey
Aktive Positionen von Merdad Parsey
| Unternehmen | Position | Beginn |
|---|---|---|
| ARRIVENT BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 28.04.2025 |
| ARDELYX, INC. | Direktor/Vorstandsmitglied | 28.04.2025 |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Direktor/Vorstandsmitglied | - |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Private Equity Investor | 01.09.2026 |
Ehemalige bekannte Positionen von Merdad Parsey
| Unternehmen | Position | Ende |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Vorstandsvorsitzender | 01.01.2019 |
| GILEAD SCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2025 |
| ARCUS BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 06.02.2025 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01.11.2019 |
| REGENERON PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 |
Ausbildung von Merdad Parsey
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
92
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for oncology, CNS, urology and rare diseases | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Roche Group
 Roche Group Real Estate DevelopmentFinance Manages real estate properties | Finance |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sagimet Biosciences, Inc.
 Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
Ardelyx, Inc.
 Ardelyx, Inc. Pharmaceuticals: MajorHealth Technology Discovers and Develops therapeutic therapeutic drugs that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases | Health Technology |
Gilead Foundation
 Gilead Foundation The Gilead Foundation is a company based in Foster City, CA. | |
New York University School of Medicine
 New York University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland Baltimore County
 University of Maryland Baltimore County Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Arrivent BioPharma, Inc.
 Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
